Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-02-09

Clinical Trial Update: Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass [NA]

View source ↗

Summary

Clinical trial update describing the use of proteomic profiling to help diagnose ovarian cancer in patients undergoing surgery for an abnormal pelvic mass.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Fallopian Tube Cancer, Ovarian Cancer | NA | Status: UNKNOWN